4.81
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Brainstorm Cell Therapeutics Inc | BCLI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.16 | 3.44% | 4.81 | 4.7302 | 4.94 | 4.76 | 4.65 | 19:40:26 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 4.54 | 4.95 | 0.41 | 8.28% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,967 | 485,429 | $ 4.82 | $ 2,337,964 | 915,590 | 3.36 - 10.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 3,096 | $ 4.81 | USD |
Brainstorm Cell Therapeu... Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 134.90M | 28.05M | $ -13.95M | -1.06 | - | 23.86M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 8.00 | 20.30% |
Brainstorm Cell Therapeu... News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BCLI Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.94 | 5.15 | 4.26 | 4.58 | 566,951 | -0.13 | -2.63% |
| 1 Month | 8.30 | 8.4299 | 4.11 | 5.07 | 729,205 | -3.49 | -42.05% |
| 3 Months | 4.43 | 10.00 | 3.9645 | 5.90 | 747,644 | 0.38 | 8.58% |
| 6 Months | 3.83 | 10.00 | 3.36 | 5.66 | 396,112 | 0.98 | 25.59% |
| 1 Year | 4.22 | 10.00 | 3.36 | 5.35 | 246,057 | 0.59 | 13.98% |
| 3 Years | 4.49 | 10.00 | 2.88 | 4.78 | 142,412 | 0.32 | 7.13% |
| 5 Years | 4.38 | 10.00 | 1.90 | 4.17 | 148,130 | 0.43 | 9.82% |
Brainstorm Cell Therapeu... Description
| Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases. |
